Publications by authors named "Lianzi Yu"
Article Synopsis
- A fluorescence lateral flow immunoassay (F-LFIA) using nanoparticles with encapsulated molecules is developed to detect gastrin-releasing peptide precursor (proGRP) in serum samples.
- The F-LFIA was optimized to have a detection range of 10 to 5000 pg/mL, with a low detection limit of 6 pg/mL, and demonstrated excellent sensitivity, specificity, and reproducibility.
- In tests on 183 human serum samples, the F-LFIA results correlated well with standard electrochemiluminescence immunoassays, showing promise for early detection of small-cell lung cancer (SCLC).
Background: Noninvasive biomarkers for the assessment of response to chemotherapy in advanced breast cancer (BCa) are essential for optimized therapeutic decision-making. We evaluated the potential of soluble Periostin (POSTN) in circulation as a novel biomarker for chemotherapy efficacy monitoring.
Methods: Two hundred and thirty-one patients with different stages of BCa were included.